Zobrazeno 1 - 4
of 4
pro vyhledávání: ''
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionDiabetic nephropathy (DN) is the leading cause of end-stage renal disease. Due to its complex pathogenesis, new therapeutic agents are urgently needed. Orthosiphon aristatus (Blume) Miq., commonly known as kidney tea, is widely used in DN
Externí odkaz:
https://doaj.org/article/b3aed8f474424eadba05aee807db266c
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: Diabetic nephropathy (DN) is known as the most common complication of diabetes, resulting from a complex inheritance-environment interaction without effective clinical treatments. Herein, we revealed the protective effects and mechanisms
Externí odkaz:
https://doaj.org/article/9956d7b326db4281801aab23bab19aba
Autor:
Xiuhai Su, Wenxia Yu, Airu Liu, Congxiang Wang, Xiuzhen Li, Juanjuan Gao, Xiaofei Liu, Wenhui Jiang, Yue Yang, Shuquan Lv
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
San-Huang-Yi-Shen capsule (SHYS) has been used in the treatment of diabetic nephropathy (DN) in clinic. However, the mechanisms of SHYS on DN remain unknown. In this study, we used a high-fat diet (HFD) combined with streptozotocin (STZ) injection to
Externí odkaz:
https://doaj.org/article/30756142961d4a6b8954c6aa579f5b55
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Bekhogainsam decoction (BHID), a representative prescription for the treatment of diabetes mellitus (DM) and diabetic complications in both traditional Korean and Chinese medicine, was examined for its ability to ameliorate diabetic nephropathy (DN),
Externí odkaz:
https://doaj.org/article/375a84ad2fa14a4ebad6887b645fd1fd